MASI

----

Masimo Corp. initiated a federal lawsuit, accusing the U.S. Customs and Border Protection (CBP) of illegally allowing Apple Inc. to reactivate a blood oxygen tracking feature on its Apple Watch, claiming that this action infringes on its patents

Masimo Corp. initiated a federal lawsuit, accusing the U.S. Customs and Border Protection (CBP) under President Trump of illegally tolerating Apple Inc.'s reactivation of a blood oxygen tracking feature on its Apple Watch. Masimo believes that Apple's actions infringe on the company's patents

Source: Wallstreetcn The copyright of this article belongs to the original author/organization.

The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.